Title: Sepsis en stolling
Authors: Meersseman, Wouter # ×
Issue Date: 2005
Series Title: Tijdschrift voor geneeskunde vol:61 issue:18 pages:1300-1305
Abstract: Severe sepsis
During the past decade, considerable advances have been made in the knowledge of the pathophysiology of severe sepsis. In addition, randomized clinical trials of critical care interventions, such as corticosteroids in sepsis, low tidal volume ventilation, glucose control and appropiate antibiotic strategy, have reduced mortality more effectively than conventional therapy.
Advances in supportive care have not been paralleled by success with antisepsis interventions. Many trials of agents solely targeting the inflammatory cascade have failed to reduce mortality. Knowing that the immune system is closely linked to the coagulation cascade, the antithrombotic approach now offers great promise for bedside application of antisepsis therapy that will improve survival. Treatment with activated protein C decreased the 28-day mortality rate from 30.8% to 24.7%. Whether heparin is of proven benefit in established diffuse intravascular coagulation, and whether it can prevent multiple organ dysfunction in severe sepsis, needs to be proven in ongoing trials. Whether a heparin interaction with activated protein C is responsible for reduced efficacy of activated protein C when combined with heparin as seen in post-hoc analyses, is currently unknown.
ISSN: 0371-683X
Publication status: published
KU Leuven publication type: AT
Appears in Collections:Laboratory for Clinical Infectious and Inflammatory Disorders
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.